Cns Pharmaceuticals, Inc. (CNSP) SEC Filings — 2024
41 SEC filings for Cns Pharmaceuticals, Inc. (CNSP) in 2024.
Filings
- CNS Pharmaceuticals Files Current Report — 8-K · Dec 11, 2024
- CNS Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Dec 3, 2024
- Cns Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- CNS Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- CNS Pharmaceuticals Appoints New Chief Medical Officer — 8-K · Nov 1, 2024
- CNS Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Oct 28, 2024
- CNS Pharmaceuticals Files 8-K for Material Definitive Agreement — 8-K · Oct 24, 2024
- CNS Pharmaceuticals Files 8-K — 8-K · Oct 23, 2024
- CNS Pharmaceuticals Faces Nasdaq Listing Rule Non-Compliance — 8-K · Sep 18, 2024
- CNS Pharmaceuticals Faces Delisting Notice — 8-K · Sep 12, 2024
- CNS Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
- CNS Pharmaceuticals Appoints New Chief Medical Officer — 8-K · Aug 7, 2024
- Cortice Biosciences Files 13D for CNS Pharmaceuticals — SC 13D · Aug 2, 2024
- CNS Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · Jul 30, 2024
- CNS Pharmaceuticals Files Material Definitive Agreement — 8-K · Jul 26, 2024
- CNS Pharmaceuticals Faces Nasdaq Delisting Warning — 8-K · Jul 24, 2024
- CNS Pharmaceuticals Files S-1/A Amendment — S-1/A · Jul 19, 2024
- CNS Pharmaceuticals Files S-1 for Public Offering — S-1 · Jul 12, 2024
- CNS Pharmaceuticals Appoints New Chief Medical Officer — 8-K · Jul 9, 2024
- CNS Pharmaceuticals Raises $1M in Stock Sale — 8-K · Jul 3, 2024
- Cns Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Jul 2, 2024
- CNS Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · Jun 26, 2024
- Cns Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Jun 25, 2024
- CNS Pharmaceuticals Files 8-K Amendment — 8-K/A · Jun 20, 2024
- CNS Pharmaceuticals Closes $1.5M Stock Sale — 8-K · Jun 14, 2024
- CNS Pharmaceuticals Files S-1 for Future Offering — S-1 · Jun 10, 2024
- CNS Pharmaceuticals Closes $1.5M Private Placement — 8-K · Jun 5, 2024
- CNS Pharmaceuticals Files 8-K — 8-K · May 16, 2024
- CNS Pharmaceuticals Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- CNS Pharmaceuticals Appoints New Chief Medical Officer — 8-K · May 7, 2024
- CNS Pharmaceuticals Announces Board Changes and Officer Appointments — 8-K · May 3, 2024
- CNS Pharmaceuticals Files 8-K — 8-K · Apr 15, 2024
- CNS Pharmaceuticals, Inc. Announces 2024 Annual Meeting of Stockholders on April 30 — DEF 14A · Apr 10, 2024
- CNS Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
- CNS Pharma Faces Delisting Notice, Announces Officer Changes — 8-K · Feb 27, 2024
- CNS Pharmaceuticals to Delist from Nasdaq, Move to OTCQB — 8-K · Feb 21, 2024
- Cns Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- CNS Pharma Enters Material Agreement, Signals Leadership Changes — 8-K · Feb 2, 2024
- CNS Pharma Reports Executive/Director Changes, Comp Arrangements — 8-K · Jan 23, 2024
- CNS Pharmaceuticals Files S-1/A Amendment — S-1/A · Jan 22, 2024
- CNS Pharmaceuticals Files S-1/A Amendment — S-1/A · Jan 10, 2024